Penumbra, Inc. has introduced a significant advancement in vascular embolization with the FDA-cleared Ruby® XL System — the longest, largest, and softest coil currently available in the market. This innovative system includes Ruby XL, POD® XL, and Packing Coil XL technologies, all designed to be delivered through a standard 0.035"+ diagnostic catheter. With a primary diameter of .030" and lengths reaching up to 70 cm, the system provides higher coil volume per deployment, enabling physicians to manage large vessel and high-flow embolizations with greater ease and control.

The Ruby XL System is uniquely engineered for procedural efficiency and precise vessel occlusion. The 3D complex-shaped Ruby XL coil offers versatile framing for aneurysms, while the POD XL introduces a three-in-one occlusion design ideal for high-flow vessels — combining anchoring, framing, and dense filling in a single coil. Meanwhile, the Packing Coil XL utilizes liquid metal wave shape technology that adapts dynamically to varying vessel sizes, ensuring a dense, consistent fill. These technologies together offer physicians more flexibility in managing complex embolization cases with fewer coil deployments.

This launch further strengthens Penumbra’s commitment to expanding its peripheral embolization portfolio, providing clinicians with one of the most comprehensive coil offerings in the field. The enhanced coil volume not only has the potential to reduce radiation exposure and procedure time but may also contribute to cost savings. By addressing both clinical and operational needs, the Ruby® XL System positions Penumbra at the forefront of innovation in interventional medicine.